VCURA Trademark

Trademark Overview

On Wednesday, July 15, 2020, a trademark application was filed for VCURA with the United States Patent and Trademark Office. The USPTO has given the VCURA trademark a serial number of 90054114. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Monday, November 24, 2025. This trademark is owned by Dr. Kenneth Adams Medicine Professional Corporation. The VCURA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations with antiviral properties for use in the treatment of upper and lower respiratory infections, namely, flus and common colds caused by viruses, adenovirus, arbovirus, arenavirus, picornavirus, coronavirus, COVID-19, syncytial virus, hyperplastic skin lesions, topical herpes simplex virus 1 and 2; pharmaceutical preparations with antiviral properties for use in the treatment of influenza, parainfluenza and viral infections, namely, cold sores, genital herpes, varicella herpes, zoster 'shingles' and viral infections of the skin, namely, warts, skin tags and plantar warts, conjunctivitis, and herpetic keratitis
vcura

General Information

Serial Number90054114
Word MarkVCURA
Filing DateWednesday, July 15, 2020
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateMonday, November 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2025

Trademark Statements

Goods and Servicespharmaceutical preparations with antiviral properties for use in the treatment of upper and lower respiratory infections, namely, flus and common colds caused by viruses, adenovirus, arbovirus, arenavirus, picornavirus, coronavirus, COVID-19, syncytial virus, hyperplastic skin lesions, topical herpes simplex virus 1 and 2; pharmaceutical preparations with antiviral properties for use in the treatment of influenza, parainfluenza and viral infections, namely, cold sores, genital herpes, varicella herpes, zoster 'shingles' and viral infections of the skin, namely, warts, skin tags and plantar warts, conjunctivitis, and herpetic keratitis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 12, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDr. Kenneth Adams Medicine Professional Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto ON M2R3Y8
CA
Party NameDr. Kenneth Adams Medicine Professional Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto ON M2R3Y8
CA

Trademark Events

Event DateEvent Description
Saturday, July 18, 2020NEW APPLICATION ENTERED
Thursday, July 23, 2020TEAS PETITION TO DIRECTOR RECEIVED
Wednesday, August 5, 2020ASSIGNED TO PETITION STAFF
Wednesday, August 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 13, 2020PETITION TO DIRECTOR DENIED
Friday, August 14, 2020TEAS PETITION TO DIRECTOR RECEIVED
Monday, August 31, 2020ASSIGNED TO PETITION STAFF
Tuesday, September 1, 2020PETITION TO DIRECTOR GRANTED
Tuesday, September 1, 2020ASSIGNED TO EXAMINER
Thursday, September 3, 2020NON-FINAL ACTION WRITTEN
Thursday, September 3, 2020NON-FINAL ACTION E-MAILED
Thursday, September 3, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 15, 2021SUSPENSION LETTER WRITTEN
Monday, March 15, 2021LETTER OF SUSPENSION E-MAILED
Monday, March 15, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 15, 2021SUSPENSION INQUIRY WRITTEN
Wednesday, September 15, 2021INQUIRY TO SUSPENSION E-MAILED
Wednesday, September 15, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, February 15, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, February 18, 2022ASSIGNED TO LIE
Friday, February 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 1, 2022SUSPENSION LETTER WRITTEN
Tuesday, March 1, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, March 1, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 30, 2022SUSPENSION INQUIRY WRITTEN
Tuesday, August 30, 2022INQUIRY TO SUSPENSION E-MAILED
Tuesday, August 30, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, September 1, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, September 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 7, 2022SUSPENSION LETTER WRITTEN
Wednesday, September 7, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, September 7, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 9, 2023SUSPENSION INQUIRY WRITTEN
Thursday, March 9, 2023INQUIRY TO SUSPENSION E-MAILED
Thursday, March 9, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, March 14, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, March 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 28, 2023SUSPENSION LETTER WRITTEN
Tuesday, March 28, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, March 28, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 26, 2023SUSPENSION INQUIRY WRITTEN
Tuesday, September 26, 2023INQUIRY TO SUSPENSION E-MAILED
Tuesday, September 26, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, September 27, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, September 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 28, 2023SUSPENSION LETTER WRITTEN
Thursday, September 28, 2023LETTER OF SUSPENSION E-MAILED
Thursday, September 28, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, March 27, 2024SUSPENSION INQUIRY WRITTEN
Wednesday, March 27, 2024INQUIRY TO SUSPENSION E-MAILED
Wednesday, March 27, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, March 28, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, April 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 11, 2024SUSPENSION LETTER WRITTEN
Thursday, April 11, 2024LETTER OF SUSPENSION E-MAILED
Thursday, April 11, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 6, 2025SUSPENSION INQUIRY WRITTEN
Monday, January 6, 2025INQUIRY TO SUSPENSION E-MAILED
Monday, January 6, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, January 9, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, January 23, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 23, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 3, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 4, 2025LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 19, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 25, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 25, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 22, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 24, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, November 24, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 24, 2025TEAS PETITION TO REVIVE RECEIVED
Monday, November 24, 2025PETITION TO REVIVE-GRANTED
Monday, November 24, 2025NOTICE OF REVIVAL - E-MAILED
Monday, November 24, 2025SOU EXTENSION RECEIVED WITH TEAS PETITION

Related Keywords

vcura infections namely skin herpes pharmaceutical virus viral warts treatment properties